Abstract:Abstract Background: Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by autoantibody production and multi-organ dysfunction. SLE patients are at an elevated risk of sepsis due to immune dysregulation. Sepsis is a life-threatening condition resulting from dysregulated responses to infection and is the leading cause of ICU admission and death in SLE patients. However, the common mechanism of immune dysregulation shared between these two diseases still remains unclear. Methods: Sepsis and SLE datasets were harvested from the Gene Expression Omnibus and Single Cell Portal database. Differential expression and weighted gene co-expression network analysis (WGCNA) were used to identify essential hub genes crucial to sepsis and SLE. The least absolute shrinkage and selection operator (LASSO) regression was used to establish a diagnostic model for SLE, and a receiver operating characteristic (ROC) curve was performed to assess the diagnostic efficiency of the model for SLE and individual genes for sepsis. Single-cell RNA sequencing data of PBMCs from patients with sepsis or SLE were analyzed to evaluate the proportion of different immune cell types. The expression profiles of hub genes in sepsis and SLE patients were further investigated, and similar pathway changes were explored by Gene Set Enrichment Analysis and Gene Ontology (GO) enrichment analysis. Results: We identified 49 co-upregulated and 44 co-downregulated genes between sepsis and SLE datasets. GO analyses of these differentially expressed genes (DEGs) showed that they mainly affected the defence response to the bacteria and immune response. Combined DEGs and WGCNA analysis, we identified 11 hub genes: ANKRD22 , RSPH9 , DHRS9 , AIM2 , CCNA1 , CEACAM1 , FBXO6 , TNFAIP6 , FCGR1A , PLSCR1 , and FCGR1BP . LASSO regression analysis and ROC curve highlighted TNFAIP6 and PLSCR1 as key genes with strong diagnostic values for sepsis and SLE. Single-cell RNA analysis showed an elevated proportion of CD14 + monocytes in sepsis and SLE patients, and hub gene expression was significantly increased in this group. Meanwhile, CD14 + monocytes in these two diseases shared some common transcriptional changes. Conclusion: TNFAIP6 and PLSCR1 are essential genes with strong diagnostic values for sepsis and SLE. In addition, the proportion of CD14 + monocytes within PBMCs of sepsis and SLE patients increased, with indications of some shared transcriptional changes.

Comprehensive Transcriptome Profiling of Peripheral Blood Mononuclear Cells from Patients with Sepsis

Insights into the Molecular Mechanisms in Sepsis with Microarray Technology.

Single-cell transcriptomics reveals the alteration of peripheral blood mononuclear cells driven by sepsis

Bulk and Single-Cell Transcriptome Analysis Reveal Shared Key Genes and Patterns of Immune Dysregulation in Sepsis and Systemic Lupus Erythematosus

Integrative analysis of metabolomics and transcriptomics to uncover biomarkers in sepsis

Commonly Expressed Key Transcriptomic Profiles of Sepsis in the Human Circulation and Brain Via Integrated Analysis.

Quantitative proteomic reveals the differences of peripheral blood mononuclear cells in the host immune response to sepsis

Identification of Potential Biomarkers and Immune Features of Sepsis Using Bioinformatics Analysis

Single-cell RNA sequencing reveals cell–cell communication and potential biomarker in sepsis and septic shock patients

Identifying Six Chromatin Remodeling-related Genes As Diagnostic Biomarkers in Sepsis Using Bioinformatic Analyses

Classification of subtypes and identification of dysregulated genes in sepsis

Screening of potential immune-related genes expressed during sepsis using gene sequencing technology

Identification of Potential Early Diagnostic Biomarkers of Sepsis

Shared and Distinct Aspects of the Sepsis Transcriptomic Response to Fecal Peritonitis and Pneumonia

Comprehensive Analysis of Common Different Gene Expression Signatures in the Neutrophils of Sepsis.

Identification of key biomarkers and therapeutic targets in sepsis through coagulation-related gene expression and immune pathway analysis

Screening of prognostic core genes based on cell–cell interaction in the peripheral blood of patients with sepsis

Integrated multi-omics and artificial intelligence to explore new neutrophils clusters and potential biomarkers in sepsis with experimental validation

Identification of key genes as potential diagnostic biomarkers in sepsis by bioinformatics analysis

Master Genes and Co-Expression Network Analysis in Peripheral Blood Mononuclear Cells of Patients with Gram-Positive and Gram-Negative Sepsis

Exploring the biomarkers and potential therapeutic drugs for sepsis via integrated bioinformatic analysis